Urogen Pharma Insider Sold Shares Worth $400,000, According to a Recent SEC Filing
Mark Schoenberg, Chief Medical Officer, on July 09, 2026, sold 10,000 shares in Urogen Pharma (URGN) for $400,000. Following the Form 4 filing with the SEC, Schoenberg has control over a total of 119,763 ordinary shares of the company, with 119,763 shares held directly. SEC Filing: Price: $39.70, Change: $-0.53, Percent Change: -1.32%
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.